Marinus Pharmaceuticals reported 10.11M in Sales Revenues for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Acadia Pharmaceuticals ACAD:US $ 131.61M 16.39M
Adamas Pharmaceuticals ADMS:US 25.9M 3.92M
ALKERMES ALKS:US $ 294.14M 9.58M
Amgen AMGN:US $ 6706M 180M
Aptinyx Inc APTX:US $ 0 0
Arena Pharmaceuticals ARNA:US $ 0M 0M
Biogen BIIB:US $ 2778.9M 3.9M
Eisai 4523:JP Y 163458M 35436M
Enanta Pharmaceuticals ENTA:US $ 23.58M 1.95M
Esperion Therapeutics ESPR:US $ 14.41M 26.25M
Gilead Sciences GILD:US $ 7421M 1204M
Intercept Pharmaceuticals ICPT:US $ 92.83M 3.75M
Intra Cellular Therapies ITCI:US $ 22.21M 2.16M
Marinus Pharmaceuticals MRNS:US 10.11M 8.21M
Minerva Neurosciences NERV:US $ 0 0
Neurocrine Biosciences NBIX:US $ 296M 7.1M
Ptc Therapeutics PTCT:US $ 138.74M 22.07M
Regeneron Pharmaceuticals REGN:US $ 3452.8M 1685.7M
Sarepta Therapeutics SRPT:US $ 189.41M 25.32M
Supernus Pharmaceuticals SUPN:US $ 148.46M 7.14M
Vertex Pharmaceuticals VRTX:US $ 1984.16M 190.79M
YTE INCY:US $ 812.99M 107.28M
Zogenix ZGNX:US $ 22.61M 3.82M